CVS Health Corporation(CVS)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CVS | 124.32 B | 25.65x | 7.10% | 1.18% | $3.79 | 6.21% | 0.95 | 2.86% | $110.00 | $67.46 |
CI | 75.64 B | 11.96x | 6.70% | 2.27% | $23.94 | 16.76% | 0.74 | 2.24% | $310.19 | $235.50 |
LH | 26.88 B | 27.60x | 5.80% | 6.99% | $12.01 | 11.73% | 0.79 | 86.00% | $341.07 | $242.07 |
DGX | 26.42 B | 25.69x | 10.20% | 9.19% | $9.32 | 14.60% | 0.81 | 1.42% | $247.19 | $168.97 |
Peer Valuation & Performance Analysis
Peer group analysis for CVS Health Corporation (CVS) compared to its primary competitors (including CI, LH, DGX) reveals distinct metrics. CVS trades at a valuation premium compared to its competitors, with a P/E ratio of 25.6x versus the peer average of 21.7x (representing a 18% premium). This indicates that the market expects superior growth or commands a quality premium for CVS. In terms of growth, CVS's revenue growth of 7.1% is consistent with the peer average of 7.6%. Additionally, its net margin of 1.2% is below the peer average of 6.1%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CVS ranks #2 in P/E ratio, #2 in revenue growth, and #4 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $97.10 | $98.07 | $95.67 | $97.20 | 4,783,100 | +0.10% |
| 2026-09-02 | $97.82 | $98.50 | $96.90 | $97.23 | 5,401,700 | -0.60% |
| 2026-09-01 | $94.99 | $97.61 | $94.68 | $97.60 | 8,611,400 | +2.75% |
| 2026-08-31 | $93.22 | $94.37 | $92.85 | $93.91 | 10,674,700 | +0.74% |
| 2026-08-28 | $93.40 | $93.93 | $93.01 | $93.06 | 3,993,100 | -0.36% |
| 2026-08-27 | $93.60 | $94.15 | $92.85 | $92.92 | 4,327,700 | -0.73% |
| 2026-08-26 | $93.15 | $94.86 | $92.91 | $94.32 | 6,160,800 | +1.26% |
| 2026-08-25 | $94.11 | $94.11 | $92.71 | $92.90 | 4,102,000 | -1.29% |
| 2026-08-24 | $93.15 | $94.19 | $92.54 | $94.11 | 9,230,700 | +1.03% |
| 2026-08-21 | $94.00 | $94.39 | $92.35 | $93.02 | 5,591,900 | -1.04% |
| 2026-08-20 | $93.23 | $94.26 | $93.21 | $93.65 | 6,439,600 | +0.45% |
| 2026-08-19 | $95.41 | $95.91 | $93.26 | $93.65 | 6,351,200 | -1.84% |
| 2026-08-18 | $94.37 | $95.25 | $93.89 | $94.91 | 6,854,100 | +0.57% |
| 2026-08-17 | $96.29 | $96.50 | $93.74 | $94.01 | 7,298,800 | -2.37% |
| 2026-08-14 | $94.60 | $97.51 | $94.41 | $97.16 | 9,436,200 | +2.71% |
Explore More Analysis for CVS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.